Author(s): Zweigner J, Schumann RR, Weber JR
Abstract Share this page
Abstract Lipopolysaccharide-binding protein (LBP) has a well-established role in Gram-negative infection. New data suggest a more expanded role for LBP as a general recognition molecule. Several bacterial surface components from Gram-positive pathogens are also recognized by this molecule. LBP may also serve as a clinical marker in severe infections and may carry therapeutic potential.
This article was published in Microbes Infect
and referenced in Journal of Clinical & Cellular Immunology